Inger Vedin
Impact in
- Nutrition and Dietetics top 0.5%
- Fatty Acid Research and Health
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Fatty Acid Research and Health 17
-
- Eicosanoids and Hypertension Pharmacology 5
- Co-authors
- Jan PalmbladTommy CederholmYvonne Freund‐LeviLars‐Olof WahlundMaria EriksdotterHans BasunGerd Faxén IrvingAnita Garlind
- Journals
- Journal of Alzheimer s Disease (5 papers)International Archives of Allergy and Immunology (3 papers)The FASEB Journal (3 papers)American Journal of Clinical Nutrition (2 papers)Journal of Lipid Research (2 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Inger Vedin
36 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Nutrition and Dietetics 913
- Biochemistry 288
- Biological Psychiatry 82
- Physiology 843
- Neurology 232
Countries citing papers authored by Inger Vedin
This map shows the geographic impact of Inger Vedin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Vedin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Vedin more than expected).
Fields of papers citing papers by Inger Vedin
This network shows the impact of papers produced by Inger Vedin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Vedin. The network helps show where Inger Vedin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Inger Vedin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 9 | |
| 2 | 2017 | 49 | |
| 3 | 2015 | 70 | |
| 4 | 2014 | 18 | |
| 5 | Effects of a DHA rich omega-3 fatty acid supplementation for Alzheimer disease patients on fatty acid composition in cerebrospinal fluid, disease biomarkers and cognition : The OmegAD study | 2012 | 1 |
| 6 | 2012 | 69 | |
| 7 | 2012 | 74 | |
| 8 | 2010 | 16 | |
| 9 | 2009 | 43 | |
| 10 | 2009 | 79 | |
| 11 | 2008 | 137 | |
| 12 | 2008 | 56 | |
| 13 | 2007 | 147 | |
| 14 | 2007 | 32 | |
| 15 | ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study Hit paper breakdown → | 2006 | 571 |
| 16 | Inflammatory gene expression changes by omega-3 fatty acids in patients with Alzheimer's disease | 2004 | 1 |
| 17 | 1996 | 5 | |
| 18 | 1992 | 12 | |
| 19 | 1987 | 13 | |
| 20 | 1984 | 5 |
About Inger Vedin
Inger Vedin is a scholar working on Nutrition and Dietetics, Biochemistry, Physiology, Biological Psychiatry and Genetics, having authored 36 papers that have together received 1.9k indexed citations. Recurring topics across this work include Fatty Acid Research and Health (17 papers), Diet and metabolism studies (8 papers), Eicosanoids and Hypertension Pharmacology (5 papers), Cholesterol and Lipid Metabolism (4 papers), Alzheimer's disease research and treatments (3 papers), Diet, Metabolism, and Disease (3 papers), Immune Response and Inflammation (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Nutrition and Dietetics (913 citations), Biochemistry (288 citations), Biological Psychiatry (82 citations), Physiology (843 citations) and Neurology (232 citations). Inger Vedin has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Jan Palmblad, Tommy Cederholm, Yvonne Freund‐Levi, Lars‐Olof Wahlund, Maria Eriksdotter, Hans Basun, Gerd Faxén Irving, Anita Garlind, Bengt Vessby and Erik Hjorth. Their work appears in journals such as Journal of Alzheimer s Disease, International Archives of Allergy and Immunology, The FASEB Journal, American Journal of Clinical Nutrition and Journal of Lipid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.